COVID-19 Vaccine: A Global Race

• DOI: 10.37358/rc.20.6.8199
• Publication Date: 2020-07-01T13:04:43Z
• Authors: Kamel Earar; Vania Atudorei; Isteqlal Sami Naz...; Manuela Arbune; Valeriu Romulus H...; Ovidiu Schipor; Ana Magdalena Bratu; Cristina Serban; Serban Dragosloveanu; Silvia Fotea; Aurel Nechita
• Keywords: Pandemic; Coronavirus; 2019-20 coronavirus outbreak; Identification

The emergence of the new coronavirus SARS-CoV-2, at end 2019, triggered worst pandemic last century, called COVID-19. Unlike SARS-CoV-1, which developed as an epidemic in 1996 but was limited to Asia, SARS -CoV-2 spread rapidly millions people worldwide, with a high mortality rate. Deciphering structure viral S and SARS-CoV genome-2 allowed identification targets for vaccination, most important being protein S. development -COVID-19 vaccines is based on use innovative biotechnologies, some even experimental. Experience SARS-CoV-1-MERS-CoV may be useful designing bad vaccine by emerging virus SARS-CoV-2. Developing anti-COVID-19 efficient, safe accessible shortest possible time, remains biggest challenge overall, race limit today.